HPV疫苗纳入国家免疫计划是践行“投资于人”

Core Viewpoint - The inclusion of the HPV vaccine in the national immunization program starting November 10, 2025, represents a significant step in public health policy, aiming to enhance preventive healthcare for young girls and reduce the burden of cervical cancer in China [2][3]. Summary by Sections National Immunization Program - The HPV vaccine will be included in the national immunization program for the first time since 2007, expanding the target demographic from children under 6 to adolescents [2]. - This decision aligns with the "14th Five-Year Plan" which emphasizes the integration of investments in both material and human resources [2]. Cervical Cancer Burden - Cervical cancer is the fourth most common cancer among women in China, with increasing incidence rates and a trend towards younger patients [2]. - Vaccination against HPV is identified as the most effective and economical method for preventing cervical cancer [2]. Vaccine Coverage and Accessibility - Current HPV vaccination coverage in China is low due to factors such as lack of awareness, high vaccine prices, and limited availability [3]. - Pilot programs for free HPV vaccination have shown high acceptance rates, indicating that low coverage is more related to investment and promotion rather than public awareness [3]. Government Procurement and Cost - The government plans to procure 15.4465 million doses of the bivalent HPV vaccine at a budget of approximately 424.78 million yuan, resulting in an estimated procurement price of 27.5 yuan per dose [3]. - This reflects the government's strong bargaining power in vaccine procurement [3]. Economic and Social Impact - The HPV vaccination initiative is seen as a proactive fiscal policy that invests in public health, which can lead to significant long-term benefits for society [3][4]. - By reducing healthcare costs associated with cervical cancer, the program aims to improve the financial stability of families and the overall economic structure of society [4]. Addressing Demand Issues - The vaccination program is expected to enhance effective demand in the economy, addressing the current issue of insufficient domestic demand [4][5]. - The lack of effective demand is attributed to residents' low sense of security regarding social welfare systems, leading to higher savings rates [4]. Future Directions - To effectively alleviate domestic demand issues, there is a need for substantial investment in public welfare systems, including social security and healthcare [5][6]. - The HPV vaccination program is viewed as a practical step towards filling gaps in social welfare and enhancing public health, ultimately contributing to a more robust domestic economy [5][6].